中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

58 records (took 0.023 seconds)

    15.
    发明专利
    未知

    公开(公告)号：DK456681A

    公开(公告)日：1982-04-16

    申请号：DK456681

    申请日：1981-10-14

    Applicant: HOFFMANN LA ROCHE

    Inventor： FURLENMEIER A

    IPC: A61K31/43 ,  A61P31/04 ,  C07D295/185 ,  C07D499/00 ,  C07D499/04 ,  C07D499/21 ,  C07D499/78 ,  C07D

    Abstract: 1. Claims (for the Contracting States : CH, IT, LI, LU, NL, SE) A process for the manufacture of 6-aminopenicillanic acid derivatives of the general formula see diagramm : EP0049891,P5,F1 in which R represents hydrogen or a readily hydrolyzable ester group, as well as of pharmaceutically compatible salts of these compounds, characterized by hydrogenating a compound of the general formula see diagramm : EP0049891,P5,F2 in which R has the significance given above and R**1 signifies a hydrogenolytically cleavable group, or a salt of such a compound in the presence of palladium/carbon, whereafter, if desired, an ester of formula I obtained is subjected to an ester cleavage, if desired a carboxylic acid of formula I obtained is treated with an agent yielding the ester group R and, if desired, a compound of formula I obtained is converted into a pharmaceutically compatible salt thereof. 1. Claims (for the Contracting State : AT) A process for the manufacture of 6-aminopenicillanic acid derivatives of the general formula see diagramm : EP0049891,P5,F4 in which R represents hydrogen or a readily hydrolyzable ester group, as well as of pharmaceutically compatible salts of these compounds, characterized by hydrogenating a compound of the general formula see diagramm : EP0049891,P6,F1 in which R has the significance given above and R**1 signifies a hydrogenolytically cleavable group, or a salt of such a compound in the presence of palladium/carbon, whereafter, if desired, an ester of formula I obtained is subjected to an ester cleavage, if desired a carboxylic acid of formula I obtained is treated with an agent yielding the ester group R and, if desired, a compound of formula I obtained is converted into a pharmaceutically compatible salt thereof.

Patent Agency Ranking